Artemis Medicare Services Share Price Target 2026 Analyst Forecast Bull and Bear Case

Artemis Medicare Services (NSE: ARTEMISMED) is a Multi-Specialty Hospitals company trading at Rs 264.3 with a market capitalisation of Rs 2,113 crore. Analysts have set the Artemis Medicare Services share price target at Rs 315 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast for Artemis Medicare Services including sector tailwinds, key risks, and bull and bear scenarios.

Click Here – Get Free Investment Predictions

Artemis Medicare Services Share Price Target 2026: Key Takeaways

• Artemis Medicare Services share price target 2026: Rs 315 (20% upside from CMP Rs 264.3)
• Bull case: Rs 385 | Bear case: Rs 210
• Ticker: ARTEMISMED | Sector: Multi-Specialty Hospitals | MCap: Rs 2,113 crore
• 52W range: Rs 183 to Rs 433 | PE: 25x
• Key catalyst: Q4 FY26 results and FY27 earnings confirmation in 2026
• Key risk: FY27 earnings miss or FII outflows from Indian equities

Artemis Medicare Services Company Overview

Artemis Medicare Services (NSE: ARTEMISMED) is a Gurugram-based multi-specialty hospital group operating Artemis Hospital with 600-plus beds, providing oncology, cardiac, orthopaedics, and transplant services to NCR patients and international medical tourists. At CMP Rs 264.3 against a 52 week range of Rs 183 to Rs 433, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 2,113 crore with trailing PE of 25x. Compared to peers in hospitals like Fortis Healthcare and Max Healthcare, Artemis Medicare Services is positioned as a potential re-rating candidate toward the Rs 315 price objective on FY27 earnings delivery.

Parameter	Value
NSE Ticker	ARTEMISMED
Sector	Multi-Specialty Hospitals
CMP (2026)	Rs 264.3
52 Week High	Rs 433
52 Week Low	Rs 183
Market Cap	Rs 2,113 crore
Trailing PE	25x
12-Month Analyst Target	Rs 315
Bull Case Target	Rs 385
Bear Case Target	Rs 210

Why Is the Artemis Medicare Services Share Price Target Set at Rs 315 for 2026

FY27 Earnings Recovery and Revenue Acceleration

The Artemis Medicare Services share price target of Rs 315 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for a re-rating from CMP Rs 264.3. Until FY27 PAT delivery is confirmed, the Rs 315 objective represents a base case with execution risk attached.

Structural Sector Tailwinds in Multi-Specialty Hospitals

The Multi-Specialty Hospitals sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. Artemis Medicare Services’s market position among peers in hospitals like Fortis Healthcare and Max Healthcare creates a structural growth runway. Sustained sector outperformance is one of the key conditions for the Rs 385 bull case to materialise, making sector monitoring essential for investors tracking the stock.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle in 2026 is reducing borrowing costs across sectors and stimulating end market demand. For Artemis Medicare Services, lower interest costs improve the EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 315 analyst consensus in 2026.

Union Budget 2026-27 Capex Push and Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a favourable policy backdrop for Artemis Medicare Services’s Multi-Specialty Hospitals operations. Policy support increases the probability of Artemis Medicare Services achieving its FY27 earnings targets, supporting the Rs 315 price objective.

FII Flow Normalisation After the 2026 Tariff Shock

As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 25x PE, Artemis Medicare Services is positioned as a beneficiary of institutional reallocation into the Multi-Specialty Hospitals sector, providing a tailwind toward the Rs 385 bull case.

Artemis Medicare Services Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Artemis Medicare Services Share Price Target

Near-term support for Artemis Medicare Services is anchored close to the 52 week low of Rs 183. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating. Investors eyeing a near-term entry can use the 52 week low as a reference while awaiting the FY27 earnings confirmation that would support the full Rs 315 objective.

12-Month Artemis Medicare Services Share Price Target 2026

The 12-month Artemis Medicare Services share price target 2026 is Rs 315, implying approximately 20 percent upside from CMP Rs 264.3. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows into the Multi-Specialty Hospitals sector. Track live price on NSE under ticker ARTEMISMED.

Long Term Artemis Medicare Services Share Price Target: FY27 to FY28

The long term Artemis Medicare Services share price target for FY27 to FY28 is Rs 385 in the bull case. Full earnings delivery, re-rating toward higher peer multiples among peers in hospitals like Fortis Healthcare and Max Healthcare, and sustained institutional buying are the three conditions needed to reach Rs 385 over a 2 to 3 year horizon.

Bull Case and Bear Case Scenarios for Artemis Medicare Services in 2026

Bull Case Artemis Medicare Services Share Price Target: Rs 385

The bull case Artemis Medicare Services share price target of Rs 385 materialises when FY27 earnings beat analyst estimates, Multi-Specialty Hospitals tailwinds accelerate, and FII flows return strongly to Indian equities. Under this scenario, Artemis Medicare Services re-rates toward higher peer multiples, making Rs 385 achievable within FY28, representing approximately 45 percent upside from the current CMP of Rs 264.3.

Bear Case Artemis Medicare Services Share Price Target: Rs 210

The bear case Artemis Medicare Services share price target of Rs 210 materialises if FY27 earnings disappoint or FII outflows depress the broader market. Under this scenario, the stock risks testing 52 week low support near Rs 183, and investors should reassess the thesis before deploying additional capital.

Scenario	Target	Key Conditions
Bull Case	Rs 385	FY27 earnings beat, sector re-rating, FII inflows
Base Case (Analyst Target)	Rs 315	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 210	FY27 miss, guidance cut, FII outflows persist

Key Risks That Could Derail the Artemis Medicare Services 2026 Price Objective

Global Macro and US Tariff Headwinds

Prolonged tariff tensions triggered by the US reciprocal tariff announcement in 2026 have reduced FII risk appetite for Indian equities. A global demand slowdown or escalation in trade tensions remains a prominent macro risk to the Artemis Medicare Services share price target of Rs 315 and could push the stock toward the bear case of Rs 210.

FY27 Earnings Miss and Guidance Risk

An FY27 earnings miss or downward guidance revision would compress multiples. This is the most direct company-specific risk to the Rs 315 analyst price objective. Investors should monitor quarterly results and management commentary, especially signals about demand environment, pricing power, and margin compression in Multi-Specialty Hospitals.

Competitive Intensity Among Multi-Specialty Hospitals Peers

Intensifying competition from peers in hospitals like Fortis Healthcare and Max Healthcare could compress Artemis Medicare Services’s market share and pricing power over the medium term. This structural risk must be weighed when assessing how defensible the earnings trajectory is that underpins the Rs 315 analyst target for 2026.

Liquidity Risk and FII Selling Pressure

Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. For smaller market cap stocks, liquidity constraints can amplify drawdowns. Investors should size positions carefully and maintain stop losses to protect capital if broader market de-rating continues.

How to Invest in Artemis Medicare Services

Check the Univest Screener for live data

Before considering any investment based on the Artemis Medicare Services share price target of Rs 315, review the company’s Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, operating margin trends, debt levels, and management commentary on Multi-Specialty Hospitals sector demand and competition.

Open a Demat and trading account with a SEBI registered stockbroker to trade Artemis Medicare Services (NSE: ARTEMISMED) with regulatory protection. Before executing any order, study the competitive landscape among peers in hospitals like Fortis Healthcare and Max Healthcare to assess whether Artemis Medicare Services’s competitive position justifies the Rs 315 valuation.

Plan your entry using the 52 week low of Rs 183 as a key support reference. A confirmed FY27 earnings uptick combined with positive guidance would validate the entry case. Always set a pre-defined stop loss below the 52 week low to limit downside.

Maintain position sizing discipline. Restrict any single stock to 3 to 5 percent of your total equity portfolio, especially in the Multi-Specialty Hospitals space where sectoral cycles can amplify volatility beyond initial expectations.

Always consult a SEBI registered financial advisor before making investment decisions based on any analyst price target or market commentary. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Artemis Medicare Services’s live share price and receive daily stock recommendations from SEBI registered analysts.

FAQs on Artemis Medicare Services Share Price Target 2026

What is the Artemis Medicare Services share price target for 2026?

Ans. The Artemis Medicare Services share price target 2026 is Rs 315, implying approximately 20 percent upside from CMP Rs 264.3. The bull case target is Rs 385 and the bear case is Rs 210.

What was the Artemis Medicare Services share price target for 2025?

Ans. The 2025 price objective for Artemis Medicare Services was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 315, reflecting FY27 growth potential from the current CMP of Rs 264.3.

Is Artemis Medicare Services a good investment at Rs 264.3?

Ans. At Rs 264.3, Artemis Medicare Services offers potential upside toward Rs 315 if FY27 earnings recover as projected. Whether this represents a good entry depends on individual risk tolerance and portfolio goals. Consult a SEBI registered financial advisor before investing.

What are the key risks to the Artemis Medicare Services share price target 2026?

Ans. Key risks to the Artemis Medicare Services share price target of Rs 315 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Multi-Specialty Hospitals. Monitoring quarterly results and management guidance is essential.

What is the 52 week high and low of Artemis Medicare Services?

Ans. The 52 week high of Artemis Medicare Services is Rs 433 and the 52 week low is Rs 183. At CMP Rs 264.3, the stock is trading below its 52 week high and offers upside toward the Rs 315 analyst price objective.

What are the main growth catalysts for Artemis Medicare Services in 2026?

Ans. Primary growth catalysts for Artemis Medicare Services in 2026 include FY27 PAT recovery, Multi-Specialty Hospitals sector tailwinds, RBI rate cuts reducing cost of capital, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.

How does Artemis Medicare Services compare to its peers?

Ans. Artemis Medicare Services operates in Multi-Specialty Hospitals alongside peers in hospitals like Fortis Healthcare and Max Healthcare. At CMP Rs 264.3 with MCap Rs 2,113 crore, the company is positioned as a potential re-rating candidate toward the Artemis Medicare Services share price target of Rs 315 on FY27 earnings delivery.

What is the Artemis Medicare Services share price target for 2027?

Ans. The long-term Artemis Medicare Services share price target for FY27 to FY28 is Rs 385 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows into Indian equities. Consult a SEBI registered financial advisor for personalised guidance.